Skip to main content
  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective." measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.
No Filters Selected
          For the filters below, open and close each one at a time for the best experience
          CBE ID Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          1880 Adherence to Mood Stabilizers for Individuals with Bipolar I Disorder Centers for Medicare & Medicaid Services Endorsement Removed
          2468 Adherence to Oral Diabetes Agents for Individuals with Diabetes Mellitus Centers for Medicare & Medicaid Services Endorsement Removed
          0543 Adherence to Statin Therapy for Individuals with Cardiovascular Disease Centers for Medicare & Medicaid Services Endorsement Removed
          0569 ADHERENCE TO STATINS Health Benchmarks-IMS Health Endorsement Removed
          0545 Adherence to Statins for Individuals with Diabetes Mellitus Centers for Medicare & Medicaid Services Endorsement Removed
          0223 Adjuvant chemotherapy is recommended, or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer American College of Surgeons Endorsed
          0220 Adjuvant hormonal therapy is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0 or Stage IB – Stage III hormone receptor positive breast cancer American College of Surgeons Endorsed
          3490 Admission and Emergency Department (ED) Visits for Patients Receiving Outpatient Chemotherapy Centers for Medicare & Medicaid Services Endorsed
          0497 Admit Decision Time to ED Departure Time for Admitted Patients Centers for Medicare & Medicaid Services Endorsement Removed
          2789 Adolescent Assessment of Preparation for Transition (ADAPT) to Adult-Focused Health Care Center of Excellence for Pediatric Quality Measurement Endorsement Removed
          Displaying 31 - 40 of 1215

          The Submission Tool and Repository (STAR) is a measure database of quality performance measures that have been submitted to the previous consensus-based entity for endorsement review. The STAR database will be updated regularly as new and maintenance measures are submitted to the Partnership for Quality Measurement for endorsement review. Battelle will be providing additional enhancements to the STAR database as measure information is submitted in order to better support the accessibility of timely and accurate measure information for all interested parties.